Untargeted serum metabolomics and tryptophan metabolism profiling in type 2 diabetic patients with diabetic glomerulopathy

References

• Livingstone SJ, Levin D, Looker HC, Scottish Diabetes Research Network epidemiology group, & Scottish Renal Registry, et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA. 2015;313(1):37–44.
   PubMed Web of Science ®Google Scholar
• Di Vincenzo A, Bettini S, Russo L, et al. Renal structure in type 2 diabetes: facts and misconceptions. J Nephrol. 2020;33(5):901–907.
   PubMed Web of Science ®Google Scholar
• Collins AJ, Foley RN, Chavers B, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59(1):A7–e420.
   PubMedGoogle Scholar
• Owen EE, Robinson RR. Amino acid extraction and ammonia metabolism by the human kidney during the prolonged administration of ammonium chloride. J Clin Investig. 1963;42(2):263–276.
   PubMed Web of Science ®Google Scholar
• Tizianello A, De Ferrari G, Garibotto G, et al. Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. J Clin Investig. 1980;65(5):1162–1173.
   PubMed Web of Science ®Google Scholar
• Rhee EP, Clish CB, Ghorbani A, et al. A combined epidemiologic and metabolomic approach improves CKD prediction. JASN. 2013;24(8):1330–1338.
   Web of Science ®Google Scholar
• Wang X, Yang S, Li S, et al. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut. 2020;69(12):2131–2142.
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Connelly J, Lindon JC, et al. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov. 2002;1:153–161.
   PubMed Web of Science ®Google Scholar
• Zhao Y-Y, Rui-Chao L. Metabolomics in nephrotoxicity. Adv Clin Chem. 2014;65:69–89.
   PubMed Web of Science ®Google Scholar
• Chen YY, Hu HH, Wang YN, et al. Metabolomics in renal cell carcinoma: From biomarker identification to pathomechanism insights. Arch Biochem Biophys. 2020;695:108623.
   PubMed Web of Science ®Google Scholar
• Zhao YY. Metabolomics in chronic kidney disease. Clin Chim Acta.. 2013;422:59–69.
   PubMed Web of Science ®Google Scholar
• Zacchia M, Marchese E, Trani EM, et al. Proteomics and metabolomics studies exploring the pathophysiology of renal dysfunction in autosomal dominant polycystic kidney disease and other ciliopathies. Nephrol Dial Transplant. 2020;35(11):1853–1861.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Cheng XL, Vaziri ND, et al. UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry. Clin Biochem. 2014;47(15):16–26.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Wu SP, Liu S, et al. Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications. Chem Biol Interact. 2014;220:181–192.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Lin RC. UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics. Chem Biol Interact. 2014;215:7–16.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Cheng XL, Lin RC. Lipidomics applications for discovering biomarkers of diseases in clinical chemistry. Int Rev Cell Molecul Biol. 2014;313:1–26.
   PubMed Web of Science ®Google Scholar
• Tuttle KR, Bakris GL, Bilous RW, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014;37(10):2864–2883.
   PubMed Web of Science ®Google Scholar
• Hirayama A, Nakashima E, Sugimoto M, et al. Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy. Anal Bioanal Chem. 2012;404(10):3101–3109.
   PubMed Web of Science ®Google Scholar
• Duranton F, Lundin U, Gayrard N, et al. Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function. CJASN. 2014;9(1):37–45.
   PubMed Web of Science ®Google Scholar
• Benito S, Sánchez A, Unceta N, et al. LC-QTOF-MS-based targeted metabolomics of arginine-creatine metabolic pathway-related compounds in plasma: application to identify potential biomarkers in pediatric chronic kidney disease. Anal Bioanalchem. 2016;408(3):747–760.
   Google Scholar
• Han LD, Xia JF, Liang QL, et al. Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography-mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy. Anal Chim Acta. 2011;689(1):85–91.
   PubMed Web of Science ®Google Scholar
• Niewczas MA, Sirich TL, Mathew AV, et al. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study. Kidney Int. 2014;85(5):1214–1224.
   PubMed Web of Science ®Google Scholar
• Pena MJ, de Zeeuw D, Mischak H, et al. Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes. Nephrol Dial Transplant. 2015;30(Suppl 4):iv86–iv95.
   PubMedGoogle Scholar
• Sharma K, Karl B, Mathew AV, et al. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol: JASN. 2013;24(11):1901–1912.
   PubMed Web of Science ®Google Scholar
• Yun JH, Kim JM, Jeon HJ, et al. Metabolomics profiles associated with diabetic retinopathy in type 2 diabetes patients. PLoS One. 2020;15(10):e0241365.
   PubMed Web of Science ®Google Scholar
• Chen T, Zheng X, Ma X, et al. Tryptophan predicts the risk for future type 2 diabetes. PloS One. 2016;11(9):e0162192.
   PubMed Web of Science ®Google Scholar
• Hara K, Hirowatari Y, Shimura Y, et al. Serotonin levels in platelet-poor plasma and whole blood in people with type 2 diabetes with chronic kidney disease. Diabetes Res Clin Pract. 2011;94(2):167–171.
   PubMed Web of Science ®Google Scholar
• Saito J, Suzuki E, Tajima Y, et al. Increased plasma serotonin metabolite 5-hydroxyindole acetic acid concentrations are associated with impaired systolic and late diastolic forward flows during cardiac cycle and elevated resistive index at popliteal artery and renal insufficiency in type 2 diabetic patients with microalbuminuria. Endocr J. 2016;63(1):69–76.
   PubMed Web of Science ®Google Scholar
• Fukui M, Shiraishi E, Tanaka M, et al. Plasma serotonin is a predictor for deterioration of urinary albumin excretion in men with type 2 diabetes mellitus. Metabolism. 2009;58(8):1076–1079.
   PubMed Web of Science ®Google Scholar
• Thompson LP, Webb RC. Vascular responsiveness to serotonin metabolites in mineralocorticoid hypertension. Hypertension (Dallas, Tex.: 1979). 1987;9(3):277–281.
   PubMed Web of Science ®Google Scholar
• Najmanová I, Pourová J, Vopršalová M, et al. Flavonoid metabolite 3-(3-hydroxyphenyl)propionic acid formed by human microflora decreases arterial blood pressure in rats. Mol Nutr Food Res. 2016;60(5):981–991.
   PubMed Web of Science ®Google Scholar
• Barik S. The uniqueness of tryptophan in biology: properties, metabolism, interactions and localization in proteins. IJMS. 2020;21(22):8776.
   Google Scholar
• Tyce GM. Origin and metabolism of serotonin. J Cardiovasc Pharmacol. 1990;16(Suppl 3):S1–S7.
   PubMedGoogle Scholar
• Hasegawa Y, Suehiro A, Higasa S, et al. Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus. Thrombo Res. 2002;107(6):319–323.
   PubMed Web of Science ®Google Scholar
• Yamada K, Niki H, Nagai H, et al. Serotonin potentiates high-glucose-induced endothelial injury: the role of serotonin and 5-HT(2A) receptors in promoting thrombosis in diabetes. J Pharmacol Sci. 2012;119(3):243–250.
   PubMed Web of Science ®Google Scholar
• Kikuchi K, Saigusa D, Kanemitsu Y, et al. Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease. Nat Commun. 2019;10(1):1835.
   PubMedGoogle Scholar
• Feng YL, Cao G, Chen DQ, et al. Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease. Cell Mole Life Sci. 2019;76(24):4961–4978.
   PubMed Web of Science ®Google Scholar
• Liu JR, Miao H, Deng DQ, et al. Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation. Cell Molecul Life Sci. 2021;78(3):909–922.
   PubMed Web of Science ®Google Scholar
• Wiedeman AM, Barr SI, Green TJ, et al. Dietary choline intake: current state of knowledge across the life cycle. Nutrients. 2018;10(10):1513.
   PubMed Web of Science ®Google Scholar
• Koppe L, Fouque D, Soulage CO. Metabolic abnormalities in diabetes and kidney disease: role of uremic toxins. Curr Diab Rep. 2018;18(10):97.
   PubMed Web of Science ®Google Scholar
• Baker JR, Chaykin S. The biosynthesis of trimethylamine-N-oxide. J Biol Chem. 1962;237(4):1309–1313.
   PubMed Web of Science ®Google Scholar
• Wirtz KW, Zilversmit DB. Exchange of phospholipids between liver mitochondria and microsomes in vitro. J Biol Chem. 1968;243(13):3596–3602.
   PubMed Web of Science ®Google Scholar
• Devaux PF. Static and dynamic lipid asymmetry in cell membranes. Biochemistry. 1991;30(5):1163–1173.
   PubMed Web of Science ®Google Scholar
• Li Z, Agellon LB, Allen TM, et al. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 2006;3(5):321–331.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Gomila RM, Martorell G, et al. Quantification of xanthine- and uric acid-related compounds in urine using a "dilute-and-shoot" technique coupling ultra-high-performance liquid chromatography and high-resolution Orbitrap mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2017;1067:53–60.
   PubMed Web of Science ®Google Scholar
• Davies PM, Fairbanks LD, Safranow K, et al. An unusual patient with kidney stones composed of 1-methyluric acid. Urol Res. 2006;34(1):58–60.
   PubMedGoogle Scholar
• Mattarucchi E, Baraldi E, Guillou C. Metabolomics applied to urine samples in childhood asthma; differentiation between asthma phenotypes and identification of relevant metabolites. Biomedical Chromatography: BMC. 2012;26(1):89–94.
   PubMed Web of Science ®Google Scholar
• Valerio F, Lavermicocca P, Pascale M, et al. Production of phenyllactic acid by lactic acid bacteria: an approach to the selection of strains contributing to food quality and preservation. FEMS Microbiol Lett. 2004;233(2):289–295.
   PubMed Web of Science ®Google Scholar